FDA decision: Gedatolisib by Celcuity Inc. (July 2026)
FDA decision: Gedatolisib by Celcuity Inc. (July 2026)
Chance
Full Approval
77%
▲ 3
Full Approval
77%
▲ 3
Denied (CRL Issued)
10%
Denied (CRL Issued)
10%
Conditional / Accelerated Approval
5%
Conditional / Accelerated Approval
5%
2 more
Market Rules
Full Approval
Resolves Yes if the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is Full Approval before Aug 1, 2026.Outcome verified from AppliedXL.
Note: this event is mutually exclusive.
Timeline and payout
Market openJun 9, 2026 · 6:30pm EDT
Market closesAfter the outcome occurs
Projected payout30 minutes after closing
SeriesKXGEDATOLISIB
EventKXGEDATOLISIB-26
MarketKXGEDATOLISIB-26-FA
Insider trading is prohibited
The following are prohibited from trading this contract:
- Persons who are employed by any of the Source Agencies are not permitted to trade on the Contract.
- Persons who hold any material, non-public information on the Underlying are not permitted to trade on the Contract.
Full Approval
Odds
0% chanceMax payout